DexCom
DXCM
$85.50
Share price
-2.29%
Change (1 day)
-5.41%
Change (1 year)
Categories
Market capitalization of DexCom (DXCM)
Market cap: $8.31 Billion
As of September 2023 DexCom has a market cap of $8.31 Billion. This makes DexCom the world's 1719th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of DexCom from 2005 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $8.31 B | -81.3% |
| 2022 | $44.44 B | -14.6% |
| 2021 | $52.04 B | 46.58% |
| 2020 | $35.50 B | 77.19% |
| 2019 | $20.03 B | 85.83% |
| 2018 | $10.78 B | 116.19% |
| 2017 | $4.98 B | -1.16% |
| 2016 | $5.04 B | -24.59% |
| 2015 | $6.69 B | 57.24% |
| 2014 | $4.25 B | 65.76% |
| 2013 | $2.56 B | 171.81% |
| 2012 | $0.94 B | 50.27% |
| 2011 | $0.62 B | -25.83% |
| 2010 | $0.84 B | 128.04% |
| 2009 | $0.37 B | 351.42% |
| 2008 | $82.31 M | -67.43% |
| 2007 | $0.25 B | 1.78% |
| 2006 | $0.24 B | -33.91% |
| 2005 | $0.37 B |
End of Day market cap according to different sources
On Sep 24th, 2023 the market cap of DexCom was reported to be:
$33.93 Billion
$8.50 Billion
$33.93 Billion
$33.93 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $384.93 B | 4,531.82% | 🇺🇸 USA |
 Abbott Laboratories ABT | $168.86 B | 1,931.96% | 🇺🇸 USA |
 Medtronic MDT | $105.96 B | 1,175.04% | 🇮🇪 Ireland |
 Becton Dickinson BDX | $76.75 B | 823.59% | 🇺🇸 USA |
 Edwards Lifesciences EW | $42.07 B | 406.27% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $1.27 B | -84.68% | 🇺🇸 USA |
 QuidelOrtho QDEL | $4.80 B | -42.17% | 🇺🇸 USA |
 West Pharmaceutical WST | $27.66 B | 232.90% | 🇺🇸 USA |